Can Biological Drugs Diminish the Risk of Sarcopenia in Psoriatic Patients? A Systematic Review

Sarcopenia and psoriasis are different inflammatory diseases that share common comorbidities (e.g., cardiovascular diseases, metabolic syndrome, obesity, autoimmune diseases, depression). Psoriasis is a dermatosis involving the skin, joints, and nails. Its estimated prevalence is 2–4%, and the possi...

Descripción completa

Detalles Bibliográficos
Autores principales: Piętowska, Zuzanna, Nowicka, Danuta, Szepietowski, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952562/
https://www.ncbi.nlm.nih.gov/pubmed/35330186
http://dx.doi.org/10.3390/life12030435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952562/
https://www.ncbi.nlm.nih.gov/pubmed/35330186
http://dx.doi.org/10.3390/life12030435

Ejemplares similares